Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$651M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$622M |
| 3 |
Merck
MRK
|
+$496M |
| 4 |
Adobe
ADBE
|
+$446M |
| 5 |
CRH
CRH
|
+$410M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.33B |
| 2 |
Microsoft
MSFT
|
+$965M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$542M |
| 4 |
NVIDIA
NVDA
|
+$522M |
| 5 |
Linde
LIN
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.03% |
| 2 | Technology | 8.55% |
| 3 | Healthcare | 6.96% |
| 4 | Financials | 6.02% |
| 5 | Industrials | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
iShares TIPS Bond ETF
TIP
$15B
| $3.75M | ﹤0.01% |
34,957
-63,216
| -64% | -$6.75M |
|
3052
Xeris Biopharma Holdings
XERS
$1.55B
| $3.75M | ﹤0.01% |
1,695,753
+147,798
| +10% | +$382K |
|
|
FSP
3053
Franklin Street Properties
FSP
$42.2M
| $3.75M | ﹤0.01% |
1,650,841
+630,283
| +62% | +$1.5M |
|
3054
Cal-Maine
CALM
$3.75B
| $3.75M | ﹤0.01% |
63,651
-90,567
| -59% | -$5.15M |
|
3055
REX American Resources
REX
$1.36B
| $3.74M | ﹤0.01% |
127,534
-65,532
| -34% | -$1.44M |
|
|
NOAH
3056
Noah Holdings
NOAH
$589M
| $3.74M | ﹤0.01% |
327,436
+315,326
| +2,604% | +$3.66M |
|
3057
Upbound Group
UPBD
$1.12B
| $3.74M | ﹤0.01% |
106,208
-23,627
| -18% | -$789K |
|
3058
Allient
ALNT
$1.58B
| $3.74M | ﹤0.01% |
104,762
+80,970
| +340% | +$2.42M |
|
3059
CALL
Builders FirstSource
BLDR
$7.29B
| $3.73M | ﹤0.01% |
17,900
+7,900
| +79% | +$1.46M |
|
3060
Afya
AFYA
$1.29B
| $3.73M | ﹤0.01% |
200,781
+176,798
| +737% | +$3.63M |
|
3061
PUT
Tyson Foods
TSN
$19.5B
| $3.72M | ﹤0.01% |
63,400
+49,800
| +366% | +$2.73M |
|
3062
NerdWallet
NRDS
$633M
| $3.72M | ﹤0.01% |
253,004
+145,302
| +135% | +$2.25M |
|
3063
Inovio Pharmaceuticals
INO
$133M
| $3.72M | ﹤0.01% |
267,802
+232,709
| +663% | +$2.01M |
|
3064
Stepan Co
SCL
$1.42B
| $3.72M | ﹤0.01% |
41,278
+37,149
| +900% | +$3.33M |
|
3065
STAAR Surgical
STAA
$1.11B
| $3.71M | ﹤0.01% |
97,034
-408,467
| -81% | -$13.3M |
|
3066
TETRA Technologies
TTI
$1.01B
| $3.71M | ﹤0.01% |
838,164
+371,957
| +80% | +$1.55M |
|
3067
TripAdvisor
TRIP
$1.16B
| $3.71M | ﹤0.01% |
133,605
-182,222
| -58% | -$4.42M |
|
|
CIM
3068
Chimera Investment
CIM
$963M
| $3.71M | ﹤0.01% |
268,162
-653,830
| -71% | -$9.11M |
|
3069
PUT
Iron Mountain
IRM
$35B
| $3.71M | ﹤0.01% |
46,200
+42,700
| +1,220% | +$3.09M |
|
3070
Mizuho Financial
MFG
$129B
| $3.7M | ﹤0.01% |
930,846
-217,969
| -19% | -$813K |
|
3071
Amdocs
DOX
$6.57B
| $3.7M | ﹤0.01% |
40,989
-488,414
| -92% | -$44.5M |
|
3072
SolarEdge
SEDG
$1.93B
| $3.7M | ﹤0.01% |
52,153
+11,244
| +27% | +$811K |
|
3073
PUT
Avis
CAR
$4.88B
| $3.7M | ﹤0.01% |
30,200
+23,200
| +331% | +$3.2M |
|
3074
AXT Inc
AXTI
$3.84B
| $3.69M | ﹤0.01% |
804,699
+447,242
| +125% | +$1.52M |
|
3075
Nu Skin
NUS
$236M
| $3.69M | ﹤0.01% |
266,614
-10,143
| -4% | -$158K |
|
Similar funds
Israel Englander's Q1 2024 Portfolio in Review
As of Q1 2024, Israel Englander held 6,887 positions worth $234B, up 1.3% from $231B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Israel Englander's Q1 2024 filing shows 858 new, 2,292 increased, 2,484 reduced and 745 closed positions. Its largest new stake was iShares Bitcoin Trust: 20,859,447 shares worth $844M. The largest sale was iShares Core S&P 500 ETF, an estimated $4.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q1 2024 buy was iShares Bitcoin Trust: 20,859,447 shares worth $844M.
- Israel Englander added most to Merck in Q1 2024, an estimated $496M increase.
- Israel Englander's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.33B.
- Israel Englander fully exited Splunk Inc in Q1 2024, selling an estimated $319M.
- Israel Englander's ten largest holdings make up 17% of its $234B portfolio in Q1 2024.
- Israel Englander opened 858 new positions and closed 745 in Q1 2024.
- Israel Englander's portfolio value rose 1.3% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.